CN215875222U - Medical application medicine box with disinfection and anesthesia effects - Google Patents

Medical application medicine box with disinfection and anesthesia effects Download PDF

Info

Publication number
CN215875222U
CN215875222U CN202122099633.0U CN202122099633U CN215875222U CN 215875222 U CN215875222 U CN 215875222U CN 202122099633 U CN202122099633 U CN 202122099633U CN 215875222 U CN215875222 U CN 215875222U
Authority
CN
China
Prior art keywords
material layer
layer
base material
medical
medical application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202122099633.0U
Other languages
Chinese (zh)
Inventor
周群
欧阳慧
曹娟
易木林
黄建国
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Huize Bio Pharmaceutical Co ltd
Original Assignee
Hunan Huize Bio Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Huize Bio Pharmaceutical Co ltd filed Critical Hunan Huize Bio Pharmaceutical Co ltd
Priority to CN202122099633.0U priority Critical patent/CN215875222U/en
Application granted granted Critical
Publication of CN215875222U publication Critical patent/CN215875222U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The utility model provides a medical application medicine box with disinfection and anesthesia effects, which comprises a medicine box body, and a medical application, an injector and a container filled with an anesthetic, wherein the medical application, the injector and the container are packaged in the medicine box body and have the disinfection effects. The medical dressing comprises: a base material layer; a peel-off protective layer adhered to the base material layer at a peripheral portion; and an absorbent substrate layer between the peel-off protection layer and the substrate material layer; the base material layer is provided with holes for injection and channels radiating with the holes as centers. The utility model not only improves the efficiency and reduces the cost, but also reduces the risk of infection in the surgical clinical application process to a certain extent; the medical application can not only sterilize and anaesthetize at the same time or in succession, but also flexibly adjust the dosage of the anaesthetics according to individual difference, and has short effect taking time, long drug effect time and good anaesthesia and sterilization effect.

Description

Medical application medicine box with disinfection and anesthesia effects
Technical Field
The utility model belongs to the technical field of medical supplies, and provides a medical application medicine box with disinfection and anesthesia effects.
Background
Local anesthetics (localanaesthetics) are drugs which can reversibly block the generation and transmission of sensory nerve impulses when applied locally, and are called local anesthetics for short. Reversibly causing local tissue analgesia while keeping the patient awake. The action of local anesthetics is generally localized to the site of administration and rapidly diminishes as the drug diffuses from the site of administration. The currently applied methods mainly include superficial anesthesia, infiltration anesthesia, conduction anesthesia, subarachnoid anesthesia and epidural anesthesia. In surgical clinical application, generally, anesthetic is injected to perform anesthesia, but the injection anesthesia has long drug effect time, corresponding disinfection treatment is needed before injection, the time consumption is relatively long, certain pain is generated during injection, and certain psychological pressure and physiological pressure can be added to a patient. The wound is disinfected by using a disinfectant before anesthesia, and then local anesthetic is injected or smeared, so that the wound is exposed for a long time and is complex to operate, and the injection has a certain effect-taking time, and accordingly, the risk of infection in surgical clinical application is increased.
At present, the application of the sterile application is wide, more of the sterile application is single anesthesia application, and the application with a disinfection function is not common. For example, CN201620020044.5 discloses a take anesthetic applying ointment or plaster, including applying ointment or plaster the body, soak tetracaine's cotton layer and overburden, apply ointment or plaster the body and be equipped with the perforation, wherein one side fixed connection is on the body that applies ointment or plaster at perforation edge on the cotton layer edge, apply ointment or plaster the body and be equipped with the rubber coating bottom towards the skin face, apply ointment or plaster the body and pass through viscose looks adaptation with the overburden, the overburden covers at the body that applies ointment or plaster dorsad skin face, the overburden is equipped with observation window, observation window and perforation coincidence, take anesthetic applying ointment or plaster to seal in the wrapping bag. CN201980008813.6 discloses a pharmaceutical composition, a patch, a preparation method, an analgesic method and application thereof. The pharmaceutical composition comprises a single anesthetic active ingredient comprising an anesthetic active ingredient dissolved in water and an anesthetic active ingredient in an undissolved state; the mass percentage of the anesthetic active component in the pharmaceutical composition is more than 2 percent; the mass percentage of the anesthetic active ingredient dissolved in water in the pharmaceutical composition is less than 1%; the anesthetic active ingredient is lidocaine, tetracaine, bupivacaine, articaine, cinchocaine, dibucaine, etidocaine, levobupivacaine, mepivacaine, prilocaine, ropivacaine, tricaine, benzocaine or procaine. Both of the above two patents are single anesthesia application, and the wound needs to be disinfected in advance during the use process. In surgical clinical applications, disinfection and anesthesia are often used in combination, and if performed separately, they are not only costly but also time consuming, and present a risk of infection. In addition, when the injection anesthesia is performed, if adverse reactions occur during the use of a patient, the adverse reactions are difficult to stop in time and are easy to generate more serious adverse reactions.
In the existing surgical clinical application process, a disinfectant is used for disinfection first, then an anesthetic is injected, the exposure time of a skin wound is long, the operation is complex, the effect taking time after the injection of the anesthetic is long, and accordingly the infection risk in the surgical clinical application is increased. In view of the defects of the prior surgical clinical application, a medical application medicine box with the effects of disinfection and anesthesia needs to be developed, and the technical blank that the prior medical application product has the effects of disinfection and anesthesia at the same time is filled.
SUMMERY OF THE UTILITY MODEL
In order to solve the defect that the function of an application product in the prior art is too single, the utility model provides a medical application medicine box with disinfection and anesthesia effects.
Specifically, the utility model is realized by the following technical schemes:
in a first aspect, the utility model provides a medical application kit with disinfection and anesthesia effects, which comprises a kit body, and a medical application, a syringe and a container filled with an anesthetic, which are packaged in the kit body and have the disinfection effects. Further, the medical dressing kit is used separately, simultaneously or sequentially as a combined preparation for sterile anesthesia during surgical clinical application. The surgical clinical application procedure includes pre-operative, post-operative, intra-operative and other clinical studies. A medical application groove, an injector groove and a container groove filled with anesthetic are arranged in the medicine box body; sponge layers are arranged in the medical application groove, the injection groove and the container groove filled with anesthetic, and are used for protecting the transportation safety of all devices in the medicine box body.
Further, the residual amount of ethylene oxide in the medical dressing of the present invention should not be more than 10 ug/g.
Further, the disinfectant is various clinically and surgically acceptable disinfectants, and is selected from quaternary ammonium salts, biguanides and iodine-containing disinfectants, such as one or more of biquaternary ammonium salt TS-838, octadecyl trimethyl ammonium chloride, hexadecyl trimethyl ammonium bromide, cetylpyridinium chloride, benzalkonium bromide, benzalkonium chloride and dodecyl dimethyl phenoxyethyl ammonium bromide. The disinfectant solution can be prepared from the finished disinfectant on the market. The disinfectant solution mentioned in the utility model is a product which can be applied to the disinfection of human skin.
Further, the anesthetic is clinically and surgically acceptable various anesthetics, including aqueous solutions of active ingredients and buffers. Further, the active ingredient in the anesthetic is selected from the group consisting of para-aminobenzoates, amides, amino ethers, and aminoketones, for example, one selected from procaine, benzocaine, butamben, dibucaine, lidocaine, mepivacaine, dyclonine, bupivacaine, etidocaine, prilocaine, ropivacaine, oxybuprocaine, pramoxine, proparacaine, proxymetacaine, novocaine, tetracaine, and the like.
Further, the anesthetic may be varied accordingly depending on the individual unit dose used. The specific dose level for any particular patient will depend upon a variety of factors including the age, body weight, general health, sex, diet, time of administration, drug combination and the severity of the particular condition being treated.
For administration of the anesthetic by injection, the aqueous solution of the buffer contained may be in the form of a sterile injectable aqueous or nonaqueous solution or suspension. For example: 1, 3-butanediol, phosphate buffered saline, ringer's solution, isotonic sodium chloride solution and the like, or sterile, fixed oils as a solvent or suspending medium, such as mono-or diglycerides and the like. The anesthetic can be prepared from the commercial anesthetic finished product.
Further, the medical dressing comprises:
a base material layer;
a peel-off protective layer adhered to the base material layer at a peripheral portion;
and an absorbent substrate layer between the peel-off protection layer and the substrate material layer.
Further, the base material layer is made by coating medical pressure-sensitive adhesive on a material with high moisture and air permeability as a base material, wherein the base material comprises but is not limited to non-woven fabrics, gauze, polyurethane composite films, cotton cloth, silk and the like; further, the substrate material layer is provided with a hole for injection and a channel radiating with the hole as the center; the channel is arranged on one side of the substrate material layer facing the absorption substrate layer; the channels are formed by discontinuous coatings of medical pressure-sensitive adhesive, and solution among the channels can be rapidly distributed on the surface of the absorption substrate layer in a penetrating manner. The distance between the channels can be equally spaced, and the arrangement rule can be regular or irregular without special limitation. The medical pressure-sensitive adhesive can be coated by printing, spraying, reverse roll coating, extrusion coating, scraper coating and the like. And a sealing film is arranged at the inlet of the hole for injection to keep the sterile environment inside the application.
Furthermore, the peeling protective layer is a release film or paper coated with a silicone oil anti-sticking agent, and the peeling protective layer is torn off when the medical application body is used, so that the medical application body can be attached to the skin of a human body.
Further, the absorbent substrate layer comprises an absorbent material layer and a release film attached to the side of the absorbent material layer facing the peel-off protection layer. The isolating membrane can be a porous polyethylene film, a net or a grid mesh and other materials with high permeability. Furthermore, the absorption substrate layer comprises an absorption material layer formed by one or two of viscose, acetate, cuprammonium, polyester, polypropylene, polyvinyl chloride or polyester fibers and a polyethylene isolating film attached to one side of the absorption material layer facing the stripping protective layer; the absorption substrate layer is high in fit degree with the skin; the active ingredients in the patch can be contacted with the skin, and secretion, water, blood and the like on the surface of the skin can rapidly enter the patch.
Further, the absorbent material layer is loaded with a disinfectant. The preparation process of the disinfectant loaded on the absorbing material layer is as follows: and soaking the absorbing material in disinfectant solution, taking out the absorbing material after adsorption saturation, and removing moisture to obtain the absorbing material layer loaded with the disinfectant. Further, the moisture removing means includes: oven drying, freeze drying, air drying, etc.
Further, the substrate material layer and the isolation film form a cavity, and the absorption material layer is positioned in the cavities of the substrate material layer and the isolation film; the substrate material layer is connected with the isolating film in a bonding mode, a pressing mode and the like; the area of the substrate material layer is slightly larger than that of the isolating film; the fixing belts are arranged on the periphery of the base material layer and are of hook and loop fastener adhesion structures and are positioned at the same positions of two opposite sides of the base material layer; the middle of the fixing belt can be provided with an elastic band, for example, the size is adjusted, so that the absorption basal layer is convenient to be close to the skin surface; set up the magic binding face with one side fixed band, another sets up magic tape matt surface with one side fixed band.
Further, the edge of the peeling protective layer covers the edge of the base material layer, and a sterile environment of the medical application is realized before use. Clean water is used for cleaning the wound, the stripping protective layer is removed and then is applied to the wound, pathogenic bacteria on the wound are killed, the wound is placed in the aseptic environment of the application, disinfection and anesthesia are carried out simultaneously, and secondary infection and injury are prevented.
In a second aspect, the utility model provides an application of a medical application with anesthetic effect, which comprises the following specific processes:
soaking the absorbing material layer in disinfectant solution until the absorbing material layer is saturated in adsorption, and removing moisture to obtain the absorbing material layer adsorbed with the solid disinfectant;
coating the absorbing material layer to prepare a medical application;
when in use, the stripping protective layer of the medical application is removed, and the medical application is applied to the affected part through the base material layer;
covering the anesthetic solution on the surface of the absorbing material layer by injection from a container filled with anesthetic through a syringe; realize the application of disinfection and anesthesia.
In the present invention, "anesthesia" means the administration of an anesthetic compound for the purpose of tissue perception and/or reduction of pain, such as: the anesthetic can penetrate into the tissue to a sufficient depth to achieve either topical anesthesia of the skin or anesthesia of the targeted nerves and nerve branches.
The anesthetic and disinfectant in the patch of the present invention are positioned at different parts of the patch, and auxiliary materials containing mutually incompatible active ingredients are prepared, for example, in an absorption substrate layer contained in the disinfectant, the anesthetic is separately packaged (injected to the surface layer of the absorption substrate layer in use) or contained in the surface layer of the absorption substrate layer; the skin surface is reached from the same application in different ways.
The patch of the present invention contains at least a disinfectant and an anesthetic, either simultaneously or sequentially in the absorbent substrate layer, either completely or primarily in the absorbent substrate layer of the patch. The disinfectant is mainly or completely arranged in the absorption basal layer, the anesthetic is mainly or completely arranged on the surface layer of the absorption basal layer, and the disinfectant enters the absorption basal layer through active diffusion, so that two different active ingredients are sequentially transferred to the skin. The two active substances applied to the skin of the utility model have different mechanisms of transferring to the skin, and the disinfectant is transferred to the skin surface through passive administration of moisture, blood, secretion and the like contacting the skin surface under the condition of lacking moisture; the active ingredient of the anesthetic permeates from the top layer of the absorption base layer to the skin surface by active administration.
The absorbent substrate layer of the patch of the present invention serves to deliver at least one component to the skin (e.g., a planned surgical site or a wound site) in a passive administration mode, which means that an active substance (e.g., a disinfectant or anesthetic) present in the absorbent substrate layer migrates to the skin surface by dissolving with skin secretions, blood, moisture, etc. in the absence of moisture.
The active ingredient in the absorption substrate layer of the patch of the present invention is released for active administration, which means that the active substance attached to the patch actively diffuses to the skin surface only by contacting the skin in the absence of moisture to thereby achieve the effect.
Compared with the prior art, the utility model has the following beneficial effects:
(1) the utility model provides a medical application medicine box with disinfection and anesthesia effects aiming at infection risks possibly brought by separate steps of disinfection and anesthesia in the surgical clinical application process. The application of the utility model combines the disinfectant and the anesthetic for use, thereby effectively avoiding the clinical infection risk, and meanwhile, the application of the utility model can be used before, after and in the operation, thereby not only facilitating the fussy operation of the clinical doctor, but also improving the compliance of the patient, reducing the pain of the patient and simultaneously reducing the infection probability in the surgical clinical application.
(2) The disinfectant in the medical application can disinfect the skin surface under the action of secretion, blood, moisture and the like on the skin surface; the anesthetic in the medical application can reach the cortex or subcutaneous layer when being applied to the surface of the skin, and can achieve the anesthetic effect of the cortex by gathering at the pain receptor and nerve endings of the cortex, and the anesthetic effect is greatly dependent on the use time of the application and the dosage of the added anesthetic. Compared with the defects of the existing surgical clinical application, the utility model can perform anesthesia in the disinfection process, has quick response time, reduces the exposure time of the wound and is simple to operate.
(3) The medical application is simple to operate and good in time period, improves the adaptability of patients, can achieve the effects of disinfection and anesthesia, can immediately treat adverse reactions in the application process, and timely prevents more serious adverse reactions from occurring.
Drawings
Fig. 1 is a schematic structural view of a Chinese medicine application in embodiment 1 of the product of the present invention.
Fig. 2 is a schematic structural view of the inner side of the base material layer in embodiment 1 of the product of the present invention.
Fig. 3 is a schematic structural view of the outer side of the base material layer in embodiment 1 of the product of the present invention.
FIG. 4 is a cross-sectional view of a medical dressing of example 1 of a product of the present invention.
FIG. 5 is a schematic structural view of the medical application kit with disinfection and anesthesia effects provided by the present invention.
Detailed Description
The utility model is further illustrated with reference to specific examples. It should be understood that the specific embodiments described herein are illustrative only and are not limiting upon the scope of the utility model.
The examples do not show the specific techniques or conditions, according to the technical or conditions described in the literature in the field, or according to the product specifications. The reagents or instruments used are conventional products which are not known to manufacturers and are available from normal sources.
The experimental procedures in the following examples are conventional unless otherwise specified. The test materials used in the following examples are all commercially available products unless otherwise specified.
Product example 1
As shown in fig. 5, the utility model provides a medical application medicine box with disinfection and anesthesia effects, which comprises a medicine box body 4, a medical application 7 with disinfection effect, an injector 5 and a container 6 filled with anesthetic, wherein the medical application 7, the injector 5 and the container are packaged in the medicine box body 4. A medical application groove, an injector groove and a container groove filled with anesthetic are arranged in the medicine box body 4; sponge layers are arranged in the medical application groove, the injection groove and the container groove filled with anesthetic, and are used for protecting the transportation safety of all devices in the medicine box body.
As shown in fig. 1 to 4, the medical dressing comprises:
a base material layer 1;
a peel protective layer 2 bonded to the base material layer 1 at a peripheral portion;
and an absorbent substrate layer 3 between the peel-off protection layer 2 and the substrate material layer 1.
The base material layer 1 is prepared by coating medical pressure-sensitive adhesive on a material with high moisture and air permeability as a base material, wherein the base material comprises but is not limited to non-woven fabrics, gauze, polyurethane composite films, cotton cloth, silk and the like; the base material layer 1 is provided with a hole 11 for injection and a channel 12 radiating with the hole as the center; a sealing film is arranged at the inlet of the hole 11 for injection to keep the sterile environment inside the application; the channels 12 are arranged on the side of the base material layer 1 facing the absorbing base layer 3; the channels 12 are formed by discontinuous coatings of medical pressure sensitive adhesive, and the solution between the channels can be quickly distributed on the surface of the absorption substrate layer 3 in a penetrating way. The distance between the channels may be equally spaced, the arrangement rule may be regular or irregular, and there is no particular limitation, as long as the rapid permeation and distribution of the solution in the channels can be achieved, which is the protection scope of the present application, and the channels drawn in fig. 2 are only used as examples. The medical pressure-sensitive adhesive can be coated by printing, spraying, reverse roll coating, extrusion coating, scraper coating and the like.
The peeling protective layer 2 is a release film or paper coated with a silicone oil anti-sticking agent, and the peeling protective layer is torn off during use, so that the medical application body I can be attached to the skin of a human body.
The absorbent substrate layer 3 comprises an absorbent material layer 31 and a release film 32 attached to the side of the absorbent material layer facing the release-preventing layer 2. The isolating membrane can be a porous polyethylene film, a net or a grid mesh and other materials with high permeability. The absorption base layer 3 comprises an absorption material layer 31 formed by one or two of viscose, acetate, cuprammonium, polyester, polypropylene, polyvinyl chloride or polyester fiber and a polyethylene isolating film attached to one side of the absorption material layer facing the stripping protective layer 2; the absorption substrate layer is high in fit degree with the skin; the active ingredients in the patch can be contacted with the skin, and secretion, water, blood and the like on the surface of the skin can rapidly enter the patch.
The absorbent material layer 31 is loaded with a disinfectant. The preparation process of the absorbing material loaded disinfectant comprises the following steps: and soaking the absorbing material in disinfectant solution, taking out the absorbing material after adsorption saturation, and removing moisture to obtain the absorbing material layer loaded with the disinfectant. Further, the moisture removing means includes: oven drying, freeze drying, air drying, etc.
The base material layer 1 and the isolation film 32 form a cavity, and the absorption material layer 31 is positioned in the cavities of the base material layer and the isolation film; the substrate material layer 1 is connected with the isolating film 32 in a bonding mode, a pressing mode and the like; the area of the base material layer 1 is slightly larger than that of the isolation film 32; the periphery of the base material layer 1 is provided with a fixing band 11, and the fixing band 13 adopts a magic tape adhesion structure and is positioned at the same position of two opposite sides of the base material layer 1; an elastic band 131 may be disposed in the middle of the fixing band 13, for example, to adjust the size of the fixing band to facilitate the absorption substrate layer to approach the skin surface; the fastening strap 13 on the same side is provided with a hook and loop fastening surface 132, and the fastening strap 13 on the same side is provided with a hook and loop fastening surface 133.
The edge of the stripping protective layer covers the edge of the base material layer, and the sterile environment of the medical application is realized before use.
Application example 1
The utility model provides application of a medical application with an anesthesia effect, which comprises the following specific processes:
soaking the absorbing material layer in disinfectant solution until the absorbing material layer is adsorbed to saturation, and drying the absorbing material layer by using an oven or other drying instruments to remove moisture to obtain the absorbing material layer adsorbed with the solid disinfectant;
coating the absorbing material layer to prepare a medical application;
in the clinical use of surgery, the stripping protective layer of the medical application is removed, and the medical application is applied to the affected part through the base material layer;
according to the individual condition of a patient, covering the anesthetic solution on the surface of the absorption material layer in an injection mode; the application of disinfection and anesthesia is realized, and the related preoperative or postoperative and other clinical applications can be carried out after the anesthesia effect is achieved.
Detailed description of the utility model example 1
Adding 30mL of sterile water into 70mL of commercially available benzalkonium bromide solution, fully and uniformly mixing, and preparing benzalkonium bromide disinfectant with the volume ratio of 70%;
soaking the absorbing material layer in the benzalkonium bromide disinfectant for 2h, taking out, and drying in an oven to obtain a water absorbing pad with disinfecting effect;
coating the absorbing material layer to prepare a medical application;
dissolving 0.75g of commercially available bupivacaine in 10mL of 50% ethanol solution until the concentration of the bupivacaine is 7.5%, uniformly mixing and packaging for later use;
in the clinical use of surgery, the stripping protective layer of the medical application is removed, and the medical application is applied to the affected part through the base material layer;
according to the individual condition of a patient, sucking a proper amount of bupivacaine solution by using an injector to inject and cover the surface of the absorption material layer; the application of disinfection and anesthesia is realized, and the related preoperative or postoperative and other clinical applications can be carried out after the anesthesia effect is achieved.
The application of the utility model does not need to expose the wound, and can effectively reduce the infection probability. More importantly, in the using process, if anesthesia risks occur, the patch can be directly taken down, and damage can be stopped in time.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the utility model. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.

Claims (8)

1. A medical application medicine box with disinfection and anesthesia effects is characterized by comprising a medicine box body, and a medical application, an injector and a container filled with anesthetic which are packaged in the medicine box body and have the disinfection effects;
the medical dressing comprises:
a base material layer;
a peel-off protective layer adhered to the base material layer at a peripheral portion;
and an absorbent substrate layer between the peel-off protection layer and the substrate material layer;
the substrate material layer is provided with a hole for injection and a channel radiating with the hole as the center; the channel is arranged on one side of the substrate material layer facing the absorption substrate layer;
the absorption substrate layer comprises an absorption material layer and a separation film attached to one side of the absorption material layer facing the stripping protective layer, and the absorption material layer is loaded with a disinfectant.
2. The medical application kit with disinfection and anesthesia effect as claimed in claim 1, wherein said base material layer is made of a material with high moisture transmission rate as a base material coated with medical pressure sensitive adhesive.
3. The medical applicator kit having both disinfecting and anesthetic effects of claim 1, wherein said channels are formed by discrete coatings of medical pressure sensitive adhesive, the distance between the channels being equally spaced.
4. The medical dressing case with both disinfecting and anesthetic effects as claimed in claim 1, wherein a sealing film is provided at the entrance of the hole for injection.
5. The medical application kit with disinfection and anesthesia as claimed in claim 1, wherein said peel-off protection layer is a release film or paper coated with silicone oil anti-sticking agent.
6. The medical application kit with disinfection and anesthesia effect as claimed in claim 1, wherein said base material layer and the isolation film form a cavity, and said absorption material layer is located in the cavity of the base material layer and the isolation film; the area of the substrate material layer is slightly larger than that of the isolating film; the fixing belts are arranged on the periphery of the base material layer and are of hook and loop fastener adhesion structures and are positioned at the same positions of two opposite sides of the base material layer; the elastic band is arranged in the middle of the fixing band; set up the magic binding face with one side fixed band, another sets up magic tape matt surface with one side fixed band.
7. The medical dressing kit with disinfecting and anesthetic effects of claim 1, wherein the edge of said peel-off protective layer covers the edge of the base material layer.
8. The medical application medicine box with the effects of disinfection and anesthesia as claimed in claim 1, wherein the medicine box body is provided with a medical application groove, an injector groove and a container groove filled with anesthetic; sponge layers are arranged in the medical application groove, the injector groove and the container groove filled with anesthetic.
CN202122099633.0U 2021-09-01 2021-09-01 Medical application medicine box with disinfection and anesthesia effects Active CN215875222U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202122099633.0U CN215875222U (en) 2021-09-01 2021-09-01 Medical application medicine box with disinfection and anesthesia effects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202122099633.0U CN215875222U (en) 2021-09-01 2021-09-01 Medical application medicine box with disinfection and anesthesia effects

Publications (1)

Publication Number Publication Date
CN215875222U true CN215875222U (en) 2022-02-22

Family

ID=80340675

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202122099633.0U Active CN215875222U (en) 2021-09-01 2021-09-01 Medical application medicine box with disinfection and anesthesia effects

Country Status (1)

Country Link
CN (1) CN215875222U (en)

Similar Documents

Publication Publication Date Title
RU2701257C2 (en) Skin care composition delivery device
US7764993B2 (en) Iontophoretic delivery patch
AU779570B2 (en) Local prevention or amelioration of pain from surgically closed wounds
EP3096727B1 (en) Traumatic wound dressing system with conformal cover
US20030149406A1 (en) Multi-layer dressing as medical drug delivery system
US20110166498A1 (en) Methods for reducing pain using a transdermal local anesthetic patch with injection port in combination with an electromotive force
US20080027365A1 (en) Hemostatic device with oxidized cellulose pad
PT691113E (en) WASTES FOR WOUNDS
KR20070085773A (en) Systems and methods for treating warts
CN112206223A (en) System for transdermal delivery of active substances
BR112017001954B1 (en) Two-stage wound dressing set
CN103596560A (en) Sheet and liquid combination systems for dermal drug delivery
EP3096726B1 (en) Traumatic wound dressing system with wrap
US20050186260A1 (en) Medicated gel foam and method of use
US6620852B2 (en) Topical anesthetic
CN215875222U (en) Medical application medicine box with disinfection and anesthesia effects
CN113616626A (en) Medical application with anesthesia effect and application thereof
JPH02232047A (en) Germ-free adhesive foil for medical preparation
CN111615383A (en) Pharmaceutical composition, patch, preparation method, analgesic method and application thereof
JP4141898B2 (en) Method for producing wound protective agent
CN218685332U (en) A patch for loading medicine
CN212592711U (en) Alginate sterile plaster for venous wound
CN215229247U (en) Skin coating application
CN219480597U (en) Filling type adhesive bandage with medicament
RU206168U1 (en) Atraumatic dressing for the treatment of wounds in animals

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant